Abstract
In this study we measured phospholipase A (PLA) and C (PLC) activity of media filtrates and French Press lysates of the gastritis-inducing bacteriaHelicobacter pylori. We report here that bothH. pylori lysates and filtrates contain PLA1, PLA2, and C enzymes, which readily hydrolyze a radiolabeled dipalmitoylphosphatidylcholine (DPPC) and phosphorylcholine substrates, respectively. The specific activity of both PLA and C enzymes were greatest in the 6.5–7.0 and 8.4–8.8 pH ranges, respectively. Colloidal bismuth subcitrate (CBS) induced a dose-dependent inhibition of PLA2 and C activity of bothH. pylori lysates and filtrates. This inhibitory effect of CBS on PLA2 was antagonized in a dose-dependent fashion by the addition of CaCl2 to the incubation mixture, suggesting that calcium and bismuth may be competing for the same site on the enzyme. In contrast, the ability of bismuth salts to inhibit PLC activity ofH. pylori lysates was not antagonized by CaCl2. Employing a biophysical assay system for surface wettability, it was determined thatH. pylori lysates had the capacity to remove a synthetic phospholipid monolayer off a glass in a dose-dependent fashion. This ability of the bacterial lysates to catalyze the transformation of a hydrophobic surface to a wettable state was significantly attenuated in the presence of bismuth salts. Our experimental results are, therefore, consistent with the possibility thatH. pylori colonization compromises the stomach's barrier to acid by eroding a phospholipid lining, possibly a monolayer, on the surface of the gastric mucus gel and that this process is blocked in response to bismuth therapy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Andersen LP, Holck S, Poulsen CO, Elsborg L, Justensen T:Campylobacter pyloridis in peptic ulcer disease. I. Gastric and duodenal infection caused byC. pyloridis histopathologic and microbiologic findings. Scand J Gastroenterol 22:219–224, 1987
Buck GE, Gourely EG, Lee WK, Subramanyam K, Latimer JM, Di Nuzzo AR: Relation ofCampylobacter pyloridis to gastritis and peptic ulcer. J Infect Dis 153:664–669, 1986
Jones DM, Lessels AM, Eldridge J:Campylobacter-like organisms on the gastric mucosa: Culture, histological, and serological studies. Clin Pathol 37:1002–1006, 1984
Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR: Cytotoxic activity in broth-culture, filtrates ofCampylobacter pylori. J Med Microbiol 26:93–99, 1988
Marshall BJ, Warren JR: Unidentified curved bacilli in the stomachs of patients with gastritis and peptic ulceration. Lancet 1:1311–1315, 1984
Marshall BJ: TheCampylobacter pylori story. Scand J Gastroenterol 23(suppl):58–66, 1988
Price AB, Levi J, Dolby JM, Dunscombe PL, Smith A, Clark J, Stephenson ML:Campylobacter pyloridis in peptic ulcer disease: Microbiology, pathology, and scanning electron microscopy. Gut 26:1183–1188, 1985
Warren JR: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1:1273–1275, 1983
Sarosiek J, Slomiany BL: Evidence for weakening of gastric mucus integrity byCampylobacter pylori. Scand J Gastroenterol 23:585–590, 1988
Slomiany BL, Bilski J, Sarosiek J, Murty VLN, Dworkin B, VanHorn K, Zielenski J, Slomiany A:Campylobacter pyloridis degrades mucin and undermines gastric mucosal integrity. Biochem Biophys Res Commun 144:397–314, 1987
Czinn S, Carr H, Yang P: Demonstration of a soluble phosphodiesterase, phospholipase C (PLC) produced byHelicobacter pylori: A potent virulent factor. Gastroenterology 98:A34, 1990
O'Morain C, Mathai E, Daw M, Cafferky M, Keane C, O'Moore R: Lipolytic activity ofHelicobacter pylori (HP). Gastroenterology 98:A101, 1990
Slomiany BL, Kasinathan C, Slomiany A: Lipolytic activity ofCampylobacter pylori: Effect of colloidal bismuth subcitrate (De-Nol). Am J Gastroenterol 84:1273–1277, 1989
Butler BD, Lichtenberger LM, Hills BA: Distribution of surfactants in the canine GI tract and their ability to lubricate. Am J Physiol 7:G645-G651, 1983
Hills BA, Butler BD, Lichtenberger LM: Gastric mucosal barrier: The hydrophobic lining to the lumen of the stomach. Am J Physiol 7:G561-G568, 1983
Kao Y-C, Goddard PJ, Lichtenberger LM: Morphological effects of aspirin and prostaglandins on the canine gastric mucosal surface. Gastroenterology 98:592–606, 1990
Hazell SL, Lee A:Campylobacter pyloridis, urease, hydrogen ion back diffusion, and gastric ulcers. Lancet 2:15–17, 1986
Morgan DR, Freedman R, Depew CE, Kraft WG: Growth ofCampylobacter pylori in liquid media. J Clin Microbiol 25:2123–2125, 1987
Shakir KMM: Phospholipase A2 activity of post-heparin plasma: Rapid and sensitive assay and partial characterization. Anal Biochem 114:64–70, 1981
Kröner EE, Peskar BA, Fischer H, Ferber E: Control of arachidonic acid accumulation in bone marrow-derived macrophages by acyltransferases. J Biol Chem 256:3690–3697, 1981
Kurioka S, Matsuda M: Phospholipase C assay usingp-nitrophenylphosphorylcholine together with sorbitol and its application to studying the metal and detergent requirement of the enzyme. Anal Biochem 75:281–289, 1976
Romero JJ, Kao Y-C, Lichtenberger LM: Gastric protective activity of mixtures of polar and neutral lipids in rats. Gastroenterology 99:311–326, 1990
Blodgett KB: Films built by depositing successive monomolecular layers on a solid surface. J Am Chem Soc 57:1007–1022, 1935
Gaines GL: Transfer of monolayers to solid multilayers.In Insoluble Monolayers at Liquid-Gas Interfaces. GL Gaines (ed). New York, Wiley, 1966, pp 326–346
Graham DY:Campylobacter pylori and peptic ulcer disease. Gastroenterology 96:615–625, 1989
Krakowka S, Morgan DR, Kraft WG, Leunk RD: Establishment of gastricCampylobacter pylori infection in the neonatal gnotobiotic piglet. Infect Immun 55:2789–2796, 1987
Lambert JR, Borromeo M, Korman MG, Hansky J, Eaves ER: Effect of colloidal bismuth (De-Nol) on healing and relapse of duodenal ulcers—role ofCampylobacter pylordis. Gastroenterology 92:1489, 1987
Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, Phillips M, Waters TE, Sanderson CR: Prospective double-blind trial of duodenal ulcer relapse after eradication ofCampylobacter pylori. Lancet 2:1437–1442, 1988
McNulty CAM, Greaty JC, Crump B, Davis M, Donovan IA, Melikian V, Lister DM, Wise R:Campylobacter pyloridis and associated gastritis: Investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Br Med J 293:645–649, 1986
Rauws EA, Mytgat GNJ: Cure of duodenal ulcer associated with eradication ofHelicobacter pylori. Lancet 2:1233–1235, 1990
Murakami M, Yoo JK, Teramura S, Yamamoto K, Saita H, Matuok, Asada T, Kita T: Generation of a mucosa and mucosal lesion formation following hydrolysis of urea by urease in the rat stomach. J Clin Gastroenterol 12(suppl 1):S104-S109, 1990
Kawano S, Tsujii M, Fusamoto H, Sato N, Kamada T: Chronic effect of intragastric ammonia on gastric mucosal structures in rats. Dig Dis Sci 36:33–38, 1991
Marshall BJ, Barrett LJ, Prakash C, McCallum RW, Guerrant RL: Urea protectsHelicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology 99:697–702, 1990
Lichtenberger LM, Graziani LA, Dial EJ, Butler BD, Hills BA: Role of surface-active phospholipids in gastric cytoprotection. Science 219:1327–1329, 1983
Spychal RT, Goggin PM, Marrero JM, Saverymuttu SH, Yu CW, Corbishley CM, Maxwell JD, Northfield TC: Surface hydrophobicity in gastric mucosa in peptic ulcer disease: Relationship to gastritis andCampylobacter pylori infection. Gastroenterology 98:1250–1254, 1990
Goggin PM, Marrero JM, Spychal RT, Jackson PA, Corbishley CM, Northfield TC: Surface hydrophobicity of gastric mucosa inHelicobacter pylori infection: Effect of clearance and erradication. Gastroenterology 103:1486–1490, 1992
Barrett-Bee K, Hayes Y, Wilson RG, Ryley J-F: A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J Gen Microbiol 131:1217–1221, 1985
Brockerhoff H, Jensen RG: Lipolytic Enzymes. New York, Academic Press, 1974
Traynor JR, Authi KS: Phospholipase A2 activity of lysosomal origin secreted by polymorphonuclear leukocytes during phagocytosis or in treatment with calcium. Biochim Biophys Acta 665:571–577, 1981
Balsinde J, Dez E, Schuller A, Molinedo F: Phospholipase A2 activity in resting and activated human neutrophils. J Biol Chem 263:1929–1936, 1988
Slomiany BL, Slomiany A: Role of mucus in gastric mucosal protection. J Physiol Pharmacol 42:147–161, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ottlecz, A., Romero, J.J., Hazell, S.L. et al. Phospholipase activity ofHelicobacter pylori and its inhibition by bismuth salts. Digest Dis Sci 38, 2071–2080 (1993). https://doi.org/10.1007/BF01297087
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01297087